Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 1/20 | 0.52 |
| ▸ | GCGR | P47871 | 1/20 | 0.52 |
| ▸ | GIPR | P48546 | 1/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.49 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.48 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.47 |
| ▸ | VIPR2 | P41587 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31683306 | 0.93 | GLP1R (0.57) | GLP1RGCGRGIPRKISS1RBACE1 | |
| SCHEMBL31182459 | 0.91 | GLP1R (0.56) | GLP1RGCGRGIPRKISS1RBACE1 | |
| SCHEMBL30880910 | 0.91 | BACE1 (0.55) | GLP1RGCGRGIPRKISS1RBACE1 | |
| SCHEMBL29591734 | 0.90 | NPY4R (0.49) | — | |
| SCHEMBL30428639 | 0.90 | BACE1 (0.56) | GLP1RGCGRGIPRKISS1RBACE1 | |
| SCHEMBL30122982 | 0.90 | KISS1R (0.51) | KISS1RBACE1VIPR1IL23RVIPR2 | |
| SCHEMBL30880889 | 0.89 | BACE1 (0.54) | GLP1RGCGRGIPRKISS1RBACE1 | |
| SCHEMBL30974619 | 0.89 | BACE1 (0.53) | KISS1RBACE1IL23R | |
| SCHEMBL30648478 | 0.88 | GLP1R (0.57) | GLP1RGCGRGIPRKISS1RBACE1 | |
| SCHEMBL30320511 | 0.88 | BACE1 (0.47) | KISS1RBACE1IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060057-A | Clara cell protein antibody or antigen binding fragment and application thereof | 天津博奥赛斯生物科技股份有限公司 | 2026-05-19 | — | — | CN | disclosed |